Suppr超能文献

阿尔贝·莱昂·夏尔·卡尔梅特(1863 - 1933)与抗结核卡介苗接种

Albert Léon Charles Calmette (1863-1933) and the antituberculous BCG vaccination.

作者信息

Chung K T, Biggers C J

机构信息

Department of Microbiology and Molecular Cell Sciences, University of Memphis, Memphis, TN 38152, USA.

出版信息

Perspect Biol Med. 2001 Summer;44(3):379-89. doi: 10.1353/pbm.2001.0044.

Abstract

Albert Léon Charles Calmette was the first person to develop an anti-venom serum. His work revolutionized the treatment of snakebite in men and domestic animals. He is also well known for his development of the Bacillus Calmette-Guérin (BCG) vaccine for the prevention of tuberculosis. This article reviews the life experiences of this pioneer bioscientist, the current status of BCG in preventing tuberculosis, and the potential of BCG in immunotherapy for cancer.

摘要

阿尔贝·莱昂·夏尔·卡尔梅特是第一个研发抗蛇毒血清的人。他的工作彻底改变了人类和家畜蛇咬伤的治疗方法。他还因研发用于预防结核病的卡介苗(BCG)而闻名。本文回顾了这位先驱生物科学家的人生经历、卡介苗在预防结核病方面的现状以及卡介苗在癌症免疫治疗中的潜力。

相似文献

2
Léon Charles Albert Calmette and Jean-Marie Camille Guérin.莱昂·夏尔·阿尔贝·卡尔梅特和让-马里·卡米耶·介兰。
Lancet Respir Med. 2015 Mar;3(3):186-7. doi: 10.1016/S2213-2600(15)00065-X. Epub 2015 Mar 9.
7
BCG: who were Calmette and Guérin?卡介苗:卡尔梅特和介兰是谁?
Thorax. 1983 Nov;38(11):806-12. doi: 10.1136/thx.38.11.806.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验